- Open Access
Cloning and characterization of an Eimeria necatrix gene encoding a gametocyte protein and associated with oocyst wall formation
© Liu et al.; licensee BioMed Central Ltd. 2014
- Received: 25 August 2013
- Accepted: 2 January 2014
- Published: 15 January 2014
Gametocyte proteins of Eimeria (E.) spp. are important components of the oocyst wall and some have been used to develop transmission-blocking vaccines against avian coccidiosis.
Total RNA isolated from E. necatrix gametocytes was utilized as templates for RT-PCR amplification and sequencing of cDNA encoding a gametocyte protein using gene-specific primers. The cDNA was cloned into the bacterial expression vector pET28a(+) and expressed in E. coli BL21 cells. The antigenicity of the recombinant gametocyte protein and its localization in different E. necatrix life-cycle stages were determined by western blot and indirect immunofluorescence analyses, respectively.
A 731-nucleotide sequence of cDNA [GenBank: KF649255] of E. necatrix had 97.7% identity to that of Etgam22 of E. tenella. The cDNA ORF encoded a 186-amino acid protein containing a histidine-proline-rich region. The recombinant gametocyte protein (rEnGAM22) was predominately expressed in the insoluble inclusion body and recognized by antiserum from chickens immunized with oocysts of E. necatrix, E. maxima and E. tenella. A specific antibody to the rEnGAM22 protein recognized the wall-forming bodies in macrogametocytes and the walls of oocysts and sporocysts.
The gene cloned from E. necatrix gametocytes is an ortholog to Etgam22 of E. tenella and presents a potential target for future recombinant subunit vaccines against coccidiosis.
- Gametocyte protein
- Cloning and expression
Coccidiosis is a parasitic disease of the intestinal tract of most domestic and wild animals and birds that is caused by protozoan parasites of the genus Eimeria. Seven Eimeria species (E. acervulina, E. brunette, E. maxima, E. mitis, E. necatrix, E. praecox, and E. tenella) are known to infect the intestinal tracts of chickens [1, 2] and cause symptoms of coccidiosis, including weight loss, haemorrhagic diarrhea and death . Although coccidiosis is a well-known disease, it still remains one of the most economically important parasitic diseases of the poultry industry worldwide. In China alone, annual costs of in-feed medications or live vaccines for the control of Eimeria are estimated to cost 30–60 million US dollars  and the global cost is probably in the excess of $800 million annually .
Prophylactic medications have been successfully used to control avian coccidiosis, but alternative strategies are needed due to the increasing emergence of drug-resistant parasites in commercial production settings . The leading alternative to chemotherapeutic control is vaccination with live vaccines, which is dependent on vaccine-induced immune protection with oocysts comprising varied formulations of live wild-type or attenuated parasites of one or more species [7–9]. Moreover, there are several drawbacks to the use of live parasites, which include the need for cold storage, limited shelf-life of the vaccine, possible increased morbidity and mortality, and the risk of attenuated organisms reverting to a more pathogenic state. However subunit vaccines derived from intrinsic parasitic antigens or recombinant proteins from cloned DNA may overcome these difficulties .
Three gametocyte antigens (EmGAM56, EmGAM82, and EmGAM230) have been previously shown to play important roles in protection against E. maxima infections . The subunit vaccine CoxAbix® was constructed with these proteins from purified gametocytes, and conveys transmission blocking immunity  that can reduce oocyst shedding. A previous field trial showed that it was at least as effective as the response from coccidiostat-fed broiler controls . However, the purification of the gametocyte antigens is expensive, time-consuming, and laborious, because it relies on the affinity purification of the native gametocyte antigens from parasites. Hence, a substitute vaccine based on the recombinant forms of these proteins would be advantageous and is, therefore, the focus of the current research [13–15].
E. necatrix is a highly pathogenic coccidium and can cause high mortality in susceptible birds. The first and second generation meronts of E. necatrix are primarily located within in the mid-intestinal area of host chickens and later oocyst development occurs only in the caecum . Coccidiosis caused by E. necatrix mainly occurs in chickens older than 8 weeks when raised on a litter floor [17, 18].
Disease control relies exclusively on the protective immunity conferred to chickens. Therefore, to immunize chickens against E. necatrix, a planned immunization program with field isolates has been extensively implemented among breeder pullet flocks; nonetheless, such measures assumed risk of leading to outbreaks  and introducing pathogenic species into the environment. However, the development of subunit vaccines prepared from gametocyte antigens or recombinant proteins may overcome these difficulties. To the best of our knowledge, there are no previous reports regarding gametocyte antigens of E. necatrix and their genes. Therefore, the aim of the current study was to clone and identify a gametocyte antigen gene from E. necatrix, namely Engam22, according to cDNA sequences and localization characteristics of the recombinant protein within the gametocyte and oocyst wall, and to analyze the immunogenic characteristics of the recombinant protein.
Parasites and animals
The E. necatrix Yangzhou strain used in this study was isolated from chickens that died from E. necatrix infection in 2009 in Yangzhou, China, confirmed by microscopic examination and sequence analysis of the rRNA gene internal transcribed spacer (ITS) regions [20, 21], and has been maintained in our laboratory. Oocysts were passaged by oral inoculation (5000 sporulated oocysts) to 3–4-week-old Suqiu Yellow chickens that were purchased on the day of hatching from the Poultry Institute, Chinese Academy of Agricultural Sciences (Yangzhou, China), reared in a coccidia-free isolation facility, and allowed unlimited access to water and food that contained no anticoccidial drugs or antibiotics. Feces were collected on post-infection (PI) days 7–12, and unsporulated and sporulated oocysts were purified by centrifugation, salt flotation, and treatment with sodium hypochlorite as previously described .
All animal care and procedures were conducted according to the guidelines for animal use in toxicology. The study protocol was approved by the Animal Care and Use Committee of the College of Veterinary Medicine, Yangzhou University.
Gametocytes were isolated using previously published methods  with some slight modifications. Briefly, 5-week-old chickens were infected with 30 000 oocysts. At 168 h PI, the chickens were sacrificed and then guts removed and washed with cold SAC (1 mM phenylmethanesulfonyl fluoride, 1 mg/mL bovine serum albumin (BSA), 170 mM NaCl, 10 mM Tris–HCl pH 7, 10 mM glucose, and 5 mM CaCl2). The caeca were cut open and the mucosal tissues removed and incubated at 37°C in a beaker with 0.5 mg/mL of hyaluronidase in SAC. The digested mucosal tissues were filtered through a 17-μm mesh polymer filter and washed with SAC. The filtrate was then filtered through a 10-μm mesh once again, and the gametocytes accumulated on this filter were washed off with SAC and centrifuged at 3 000 rpm for 5 min and then stored at −80°C for future use.
RNA extraction and amplification of the Engam22 gene
The primers used to amplify the target gene and coding sequence of EnGAM22
Forward primer (5′-3′)
Reverse primer (5′-3′)
To confirm that the gene contained no intervening sequences, genomic DNA was isolated from purified gametocytes using the Universal Genomic DNA Extraction Kit ver. 3.0 (TaKaRa Bio., Inc.) following the manufacturer’s instructions, and then used as a template for PCR under the conditions described above.
Cloning, sequencing, and DNA analyses
The RT-PCR products were purified and cloned into the TA vector pGEM-T-easy (Promega Corp., Madison, WI, USA) following the manufacturer’s instructions, which were then transformed into chemically competent DH5α Escherichia coli cells (Invitrogen). According to blue/white spot screening, white clones were selected for sequencing by a commercial sequencing company (Beijing Genomics Institute, Beijing, China). DNA sequences were analyzed using the BLASTN nucleotide alignment tool and predicted protein sequences were analyzed using DNAstar and the online ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Recombinant protein expression and purification
Based on the DNA sequencing results, special primers (Table 1, En2) containing Eco R I and Hin d III restriction enzyme sites were designed to amplify the coding sequence of the gene excluding the signal peptide. Then, the amplicon was cloned into the bacterial expression vector pET28a(+) (Invitrogen). According to kanamycin-resistance selection, recombinant plasmids were verified by sequence analysis and transformed into chemically competent E. coli BL21 cells (Invitrogen).
Recombinant protein expression from E. coli BL21 cells grown in lysogeny broth (LB) medium containing 30 μg/mL kanamycin at 37°C was induced using 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; Promega Corp.) at an absorbance at 600 nm of 0.6. The induced bacterial cells were incubated for 4 h and then harvested by centrifugation. The cell pellets were lysed in lysis equilibrium buffer (100 mM NaH2PO4, 10 mM Tris-Cl, 8 M urea, pH 8.0) and then sonicated (2 s/3 s, for 15 min). Next, the bacterial lysates were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 12% gels and visualized after staining with Coomassie brilliant blue. The recombinant 6 × His-tagged proteins were purified from the soluble fraction of the lysate using a Ni-NTA chromatography column (GenScript, Piscataway, NJ, USA) with 500 mM imidazole (Sigma-Aldrich, St. Louis, MO, USA). After the affinity-purified proteins were renatured in renaturation buffer (50 mM Tris–HCl, 0.15 M NaCl, pH 8.0) containing 6, 4, 2, or 1 M urea at 4°C for 8 h, respectively, they were further renatured in phosphate-buffered saline (PBS; pH 8.0) at 4°C for 8 h and concentrated using polyethylene glycol (PEG8000). The yield of the purified recombinant proteins was estimated using the NanoDrop2000 spectrophotometer (Thermo Fisher Scientific) at an absorbance at 280 nm. The purified recombinant protein (rEnGAM22) was visualized on 12% SDS-PAGE after staining with Coomassie brilliant blue, aliquoted, and stored at −20°C until further use.
Generation of immune sera
Three groups of 10-day-old birds were orally inoculated with 2,000 sporulated oocysts of E. necatrix, E. tenella, and E. maxima and administered oral booster inoculations at 10 and 20 days later with of 2,500 sporulated oocysts, respectively, that were administered directly into the birds’ crops using a catheter. Blood samples were collected 7 days after the second booster. Serum was separated from the blood and stored at −80°C until further analyzed.
Mouse serum anti-rEnGAM22 was prepared as described previously [23, 24]. Briefly, rEnGAM22 was diluted to 1 mg/mL in PBS and then emulsified with an equal volume of complete or incomplete Freund’s adjuvant (Sigma-Aldrich). Six-week-old BALB/c mice were immunized three times at 2-week intervals with 0.1 mg of rEnGAM22. Blood was collected 7 days after the second booster dose. Polyclonal mouse anti-rEnGAM22 antibody was separated from the blood and stored at −80°C until required. Antibody levels in the mouse sera samples were determined using an indirect enzyme-linked immunosorbent assay (ELISA) as described below.
Immuno-blot analysis of rEnGAM22 and gametocyte extracts
rEnGAM22 was resolved over 12% SDS-PAGE and transferred onto nitrocellulose membranes for 2 h at 100 V . After blocking with 3% BSA in tris-buffered saline (TBS) for 1 h at 37°C, the membranes were incubated with anti-6 × His tag monoclonal antibody (dilution, 1:500; BBI Solutions, Cardiff, UK), mouse anti-rEnGAM22 polyclonal antibody (dilution, 1:100) or the convalescent chicken sera (dilution, 1:50) at room temperature for 1 h prior to washing three times with 0.03% Tween-20/TBS (TBST) for 10 min, respectively. The membrane-bound antibodies were then detected using horseradish peroxidase (HRP)-conjugated rabbit anti-chicken immunoglobulin G (IgG; dilution, 1:1000; GenScript) or HRP-conjugated goat anti-mouse IgG (dilution, 1:5000; Kirkegaard & Perry Laboratories, Inc. (KPL), Gathersburg, MD, USA), respectively, and developed in the presence of o-Phenylenediamine dihydrochloride (OPD) (Sigma-Aldrich) after washing five times with TBST for 10 min, respectively. Naïve sera from chicken and mice were used as a negative controls.
To confirm that the localization of EnGAM22 in the subsequent experiment was indeed only that of EnGAM22 and not in part due to cross-reactivity with higher- weight gametocyte proteins such as GAM56- or GAM82-like proteins, the gametocyte extracts were prepared following previously published techniques , and were used for immunoblot analysis under the conditions described above.
Preparation of tissue samples and indirect immunofluorescence analysis
Preparation of tissue samples and indirect immunofluorescence analysis were performed as described previously [23, 24]. Briefly, chickens were orally infected with 30,000 E. necatrix sporulated oocysts and sacrificed by CO2 inhalation and cervical dislocation at 132, 144, 156, 168, 180 and 192 h PI, respectively. The caeca and small intestines at 132 h PI were removed and fixed in 3% paraformaldehyde in PBS, respectively. Fixed tissues were embedded in paraffin, and then cut into 5 μm- thick sections using a microtome at room temperature. The paraffin was removed from the sections prior to inactivation of endogenous enzymes with 3% H2O2 and antigen retrieval using 0.1% trypsin (Promega Corp.). After blocking overnight in 5% BSA in PBS (BSA/PBS) at 4°C in a humidified chamber, the sections were incubated with mouse anti-EnGAM22 antibody (dilution, 1:100) in BSA/PBS for 1 h at 37°C, then washed in 0.03% TWEEN-20/PBS (PBST) three times for 15 min. Next, the sections were incubated with fluorescein isothiocyanate (FITC)-conjugate goat anti-mouse antibody (dilution, 1:100; KPL) in BSA/PBS for 1 h at 37°C and then rinsed in PBST as described above. The sections were then counter-stained with 4′,6-diamidino-2-phenylindole (DAPI; Roche Applied Science, Penzberg, Germany) for 5 min prior to mounting under coverslips with FluorSave Reagent (Bioworld, Consulting Laboratories, Mt. Airy, MD, USA) for visualization. Images were obtained using a Leica DM2500 reflected fluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany). Portions of the same paraffin-embedded tissue samples were also stained with hematoxylin and eosin to confirm the gametocyte and oocyst developmental processes in caecum mucosal tissues.
Preparation of oocyst walls and sporocysts and indirect immunofluorescence analysis
The purified oocyst walls and sporocysts were prepared [24, 27, 28] and indirect immunofluorescence analyses of the same were performed as described previously [29, 30]. Briefly, the sporulated oocysts (1 × 107) were washed in distilled water (2,500 rpm, 15 min, 4°C) three times to remove the 2% potassium dichromate storage solution and then resuspended in five volumes of PBS and sonicated with an output 3.0, duty cycle 30% for 3 s intervals over 4 min in an icewater bath, until about 95% of the oocyst walls were broken. The sonicate fractions containing oocyst walls and sporocysts were centrifuged at 4,000 rpm for 10 min and the subsequent pellets were collected, washed with PBS for three times resuspended in 20 volumes of 1.1 M sucrose and centrifuged at 2,500 rpm for 15 min. The top layer of fluid (sporocysts) and the pellet (oocyst walls) were collected and washed with PBS for three times, respectively. The oocyst walls and sporocysts were resuspended in methanol (−20°C) and coated on glass slides, incubated for 10 min at −20°C and washed three times with PBS for 15 min each prior to submersion in 0.1% Triton X-100 in PBS for 10 min. After washing with PBS, the slides were blocked with 3% BSA/PBS and then stained with mouse anti-rEnGAM22 antibodies (dilution, 1:50). Lastly, the samples were labeled with tetramethyl rhodamin isothiocyanate (TRITC)-conjugated goat anti-mouse antibodies dissolved in BSA/PBS (dilution, 1:100) and imaged as described above.
Engam22 isolation and sequence analysis
rEnGAM22 expression and purification
Antibody quantification by ELISA
The ELISA protocol was essentially the same as that described previously . Briefly, rEnGAM22 was diluted in 50 mM carbonate buffer (pH 9.6) and 1 μg/well was coated into 96-well microtiter plates, incubated at 4°C overnight, then washed with PBS (pH 8.0) three times for 5 min and blocked with 1% BSA for 1 h at 37°C prior to incubation with PBS-diluted mouse sera for 1 h at 37°C. After washing three times for 5 min with PBST, HRP-conjugated goat anti-mouse IgG (dilution, 1:5000; KPL) was added to each well. After incubation for 60 min at 37°C the plates were washed five times with PBST for 5 min. Finally, immune complexes were revealed by incubating with tetramethylbenzidine (TMB, Sigma-Aldrich) and 0.3% H2O2 for 10 min. The reaction was stopped by adding 2 M H2SO4 and the absorbance values was read at 450 nm using an automatic MicroELISA reader (Sunrise-Basic; Tecan Trading AG, Männedorf, Switzerland). All samples were run in triplicate. The results revealed a relatively high rEnGAM22-induced antibody level in the experimental mice. The optical density (OD) values were as high as 2.15 using diluted (1:200) immunized mouse serum, but only 0.15 with the control mouse serum.
Immunoblot analysis of rEnGAM22 and the gametocyte extracts
rEnGAM22 antibodies localized to macrogametes and developing oocyst in E. necatrix
Analysis of Engam22 revealed a 247–528 bp nucleotide sequence encoding a histidine-proline-rich region, which has been previously implicated in oocyst wall formation in E. tenella. To determine whether the EnGAM22 also played a role in oocyst wall formation, we used the mouse anti-rEnGAM22 polyclonal antibody to localize the EnGAM22 during different E. necatrix life-cycles stages.
The parasites at the same developmental stage were visible in histological sections immunostained with anti-rEnGAM22 polyclonal mouse serum and visualized with FITC (green) and counter-stained with DAPI (blue). The anti-rEnGAM22 antibody localized to the wall forming bodies of the macrogametocytes (Figure 4H, I, J) and the oocyst walls (Figure 4K, L). The anti-rEnGAM22 antibody seemed to be localised to the wall forming body type 2 (Figure 4H, J). However, the microgametes and merozoites were not recognized by the anti-rEnGAM22 antibody (Figure 4G), indicating that the EnGAM22 protein is not expressed during the schizogonic stage. In all cases, staining of the anti-rEnGAM22 polyclonal mouse serum was not observed when the tissue sections were probed with normal mouse serum.
Antibodies to rEnGAM22 localized to oocyst and sporocyst walls in E. necatrix
The coccidian oocyst wall is a bilayered structure formed from the contents of two specific organelles, types 1 and 2 wall forming bodies (WFB1 and WFB2, respectively), found exclusively in the macrogametes stage of coccidian parasites [33, 34]. The oocyst wall consists mainly of proteins and lipids [27, 28, 34]. Gametocyte proteins are precursors of the oocyst wall proteins [28, 34]. To date, only a small number of genes encoding gametocyte proteins have been cloned and sequenced from avian Eimeria species, such as Emgam56, Emgam82, and Emgam230 (a partial sequence)  in E. maxima, Etgam56 (Etgam56 tmp 1), Etgam59 (Etgam56 tmp 2) and Etgam22 in E. tenella[30, 36], and Eagam56 in E. acervulina (a partial sequence) . Other than Etgam22, which predicts a His- and Pro-rich domain , all analyses of Emgam56, Etgam56, Etgam59, and Emgam82 have predicted two distinct protein domains [25, 29, 30, 36]. Moreover, all of them are expressed specifically in gametocytes, although gametocyte-specific expression has not been detected in Etgam59. Therefore, the features of sequence characteristics and gametocyte-specific expression can be used to clone and identify the genes encoding gametocyte proteins in Eimeria species.
In the present study, we cloned a novel gene from both genomic DNA and cDNA isolated from E. necatrix gametocytes and found that the nucleotide sequences were comprised of 731 bp with a 561-bp ORF encoding a 186-aa protein. The protein deduced from the gene had a His- and Pro-rich domain. The antibody prepared against the recombinant protein expressed in E. coli BL21 cells recognized the wall-forming bodies in macrogametocytes, the walls of oocysts and sporocysts, but did not recognize either microgametes or the merozoites. In the gametocyte extracts, the anti-rEnGAM22 antibody recognized a ~36 kDa protein representing EnGAM22. These results were consistent with previous findings regarding Etgam22, and further confirmed that the gene is an E. necatrix ortholog of Etgam22 of E. tenella.
A previous study reported that both the 56 and 82 kDa gametocyte proteins in E. maxima, with true masses of 52.45 and 62.45 kDa , failed to migrate true-to-size by SDS-PAGE; particularly, the 82 kDa protein due to its unusual aa composition . Similarly, in bacterial lysates expressing the r82 construct, a 75 kDa band was detected, which migrated further than that expected of a similar recombinant protein of an expected size of 67 kDa . In the present study, both the recombinant and native EnGAM22 proteins failed to migrate true-to-size by SDS-PAGE, as the bands migrated further than that expected by theoretical molecular weights. The reason for this observation was likely due to an unusual aa composition, as in EmGAM82. Additionally, in vitro translation of Etgam 22 cDNA produced a band of ~ 25 kDa by SDS-PAGE, which also migrated less far than that expected according to the theoretical molecular weight of 22.8 kDa .
Unlike Emgam56, Etgam56, Etgam59 and Emgam82 that are single-copy intron-free genes [29, 30, 36, 37], Etgam22 is an intron-free multicopy gene with ~12 –22 copies in head-to-tail arrangement . Although Etgam22 mRNA was readily detectable in the cecal tissue samples taken from E. tenella-infected chickens at 137 h PI, the EtGAM22 protein only became detectable at 168 h PI using the E2E5 antibody via Western blot analysis when the first unsporulated oocysts appeared in the cecum . Engam22, like Etgam22, is expressed specifically at the gametocyte stage. However, the immunolocalisation results in different E. necatrix life-cycle stages revealed that Engam22 expression may occur in the mid-stage of gametocyte development (at 156 h PI), and EnGAM22 is transported into WFB2 prior to participation in the formation of the inner oocyst wall. The possible explanations for this difference may be due to the methods to detect the expression products. Furthermore, similar to Etgam22, Engam22 can be cloned directly from genomic DNA, implying Engam22 is an intron-free gene. Thus, further studies are warranted to determine whether E. necatrix Engam22 is indeed a multicopy gene.
Previous reports have confirmed that Eimeria gametocyte proteins are highly immunogenic [11, 26, 38, 39]. Vaccination with gametocyte proteins of Eimeria species induces production of immunoprotective antibodies in breeding hens, which are then transferred to the developing embryos via the egg yolk, providing partial immunity to chicks upon hatching [13, 40, 41]. The anti-EmAPGA (antibody to E. maxima affinity purified gametocyte antigens) recognized proteins within the WFBs of macrogametocytes and oocyst walls of E. maxima, E. tenella and E. acervulina, which explained the features for the vaccine (CoxAbic®) against infections of E. maxima and heterologous species such E. acervulina and E. tenella. The antibodies anti-rEmGAM56 and anti-rEmGAM82 raised against recombinant E. maxima gametocyte proteins, like anti-EmAPGA, reacted with various-sized proteins of gametocyte and oocyst preparations from E. maxima, E. tenella, and E. acervulina, in spite of only recognizing the WFB2 and inner oocyst wall via immunolocalisation analysis [33, 36]. Gametocyte antigens of both E. maxima recombinant GAM56 and GAM82 were recognized by protective chicken serum raised against APGA, and can elicit a dose-dependent antibody response in chickens, suggesting that the recombinant antigens maintain the antigenic and immunogenic properties of the native proteins . Furthermore, the recombinant GAM82 gametocyte antigen may stimulate the production of antigen-specific serum antibodies and a higher level of IL-2 and IL-15 mRNA, and induce protective intestinal immunity resulting in decreased oocysts shedding and reduced gut pathology . In the present study, an analysis was also performed to determine whether the recombinant protein rEnGAM22 was recognized by sera from chickens that had recovered from Eimeria infection. Immunoblot, analysis showed that rEnGAM22 was recognized not only by the convalescent serum from E. necatrix-infected chickens, but also by that from E. tenella- and E. maxima-infected chickens, respectively. These results suggested that antigens to E. necatrix gametocytes, like those of E. tenella and E. maxima[41, 42], might be used to develop a subunit vaccine against avian coccidiosis, and the Engam22 gene, like Emgam56 and Emgam82, might serve as a novel candidate genes to develop a recombinant subunit vaccine.
In summary, we cloned a novel gene, Engam22, encoding a gametocyte protein from E. necatrix, which is an ortholog to Etgam22 of E. tenella. Predictive analysis of this gene sequence revealed a His- and Pro-rich domain. The recombinant protein expressed in a bacterial expression vector had antigenic cross-reactivity to E. tenella and E. maxima. Engam22 expression begins in the early macrogametocyte and its native protein is involved in oocyst wall formation in E. necatrix.
This work was supported by the Jiangsu University and College Natural Science Foundation (11KJA230002), the Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20123250110002), the University Postgraduate Research and innovation projects in 2012 of Jiangsu Province (CXZZ12-0913), the Program for Changjiang Scholars and Innovative Research Team in University (IRT0978), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.
- Allen PC, Fetterer RH: Recent advances in biology and immunobiology of Eimeria species and in diagnosis and control of infection with these coccidian parasites of poultry. Clin Microbiol Rev. 2002, 15 (1): 58-65. 10.1128/CMR.15.1.58-65.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Vermeulen AN, Schaap DC, Schetters TP: Control of coccidiosis in chickens by vaccination. Vet Parasitol. 2001, 100 (1–2): 13-20.View ArticlePubMedGoogle Scholar
- Sharman PA, Smith NC, Wallach MG, Katrib M: Chasing the golden egg: vaccination against poultry coccidiosis. Parasite Immunol. 2010, 32 (8): 590-598.PubMedGoogle Scholar
- Hao L, Liu X, Zhou X, Li J, Suo X: Transient transfection of Eimeria tenella using yellow or red fluorescent protein as a marker. Mol Biochem Parasitol. 2007, 153 (2): 213-215. 10.1016/j.molbiopara.2007.02.005.View ArticlePubMedGoogle Scholar
- Shirley MW, Smith AL, Blake DP: Challenges in the successful control of the avian coccidia. Vaccine. 2007, 25 (30): 5540-5547. 10.1016/j.vaccine.2006.12.030.View ArticlePubMedGoogle Scholar
- Tewari AK, Maharana BR: Control of poultry coccidiosis: changing trends. J Parasitol Dis. 2011, 35 (1): 10-17. 10.1007/s12639-011-0034-7.View ArticleGoogle Scholar
- Williams RB: Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathol. 2002, 31 (4): 317-353. 10.1080/03079450220148988.View ArticlePubMedGoogle Scholar
- Dalloul RA, Lillehoj HS: Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Rev Vaccine. 2006, 5 (1): 143-163. 10.1586/147605188.8.131.52.View ArticleGoogle Scholar
- Lillehoj HS, Lillehoj EP: Avian coccidiosis. A review of acquired intestinal immunity and vaccination strategies. Avian Dis. 2000, 44 (2): 408-425. 10.2307/1592556.View ArticlePubMedGoogle Scholar
- Jenkins MC: Advances and prospects for subunit vaccines against protozoa of veterinary importance. Vet Parasitol. 2001, 101 (3–4): 291-310.View ArticlePubMedGoogle Scholar
- Wallach MG, Mencher D, Yarus S, Pillemer G, Halabi A, Pugatsch T: Eimeria maxima: identification of gametocyte protein antigens. Exp Parasitol. 1989, 68 (1): 49-56. 10.1016/0014-4894(89)90007-6.View ArticlePubMedGoogle Scholar
- Wallach M: The importance of transmission-blocking immunity in the control of infections by apicomplexan parasites. Int J Parasitol. 1997, 27 (10): 1159-1167. 10.1016/S0020-7519(97)00113-6.View ArticlePubMedGoogle Scholar
- Belli SI, Mai K, Skene CD, Gleeson MT, Witcombe DM, Katrib M, Finger A, Wallach MG, Smith NC: Characterisation of the antigenic and immunogenic properties of bacterially expressed, sexual stage antigens of the coccidian parasite, Eimeria maxima. Vaccine. 2004, 22 (31–32): 4316-4325.View ArticlePubMedGoogle Scholar
- Jang SI, Lillehoj HS, Lee SH, Lee KW, Park MS, Cha SR, Lillehoj EP, Subramanian BM, Sriraman R, Srinivasan VA: Eimeria maxima recombinant Gam82 gametocyte antigen vaccine protects against coccidiosis and augments humoral and cell-mediated immunity. Vaccine. 2010, 28 (17): 2980-2985. 10.1016/j.vaccine.2010.02.011.View ArticlePubMedGoogle Scholar
- Anwar MI, Akhtar M, Hussain I, Muhammad F, Haq AU: Effects of local gametocyte and livacox vaccines on live body weight gain and lymphoid organs in chickens. Pak Vet J. 2008, 28 (3): 136-138.Google Scholar
- Long PL: The biology of the coccidia. 1982, Baltimore, MD: University Park PressGoogle Scholar
- McDougald LR, Fuller AL, McMurray BL: An outbreak of Eimeria necatrix coccidiosis in breeder pullets: analysis of immediate and possible long-term effects on performance. Avian Dis. 1990, 34 (2): 485-487. 10.2307/1591441.View ArticlePubMedGoogle Scholar
- Mattiello R, Boviez JD, McDougald LR: Eimeria brunetti and Eimeria necatrix in chickens of Argentina and confirmation of seven species of Eimeria. Avian Dis. 2000, 44 (3): 711-714. 10.2307/1593117.View ArticlePubMedGoogle Scholar
- Onaga H, Kawahara F, Umeda K, Nagai S: Field basis evaluation of Eimeria necatrix-specific enzyme-linked immunosorbent assay (ELISA) for its utility in detecting antibodies elicited by vaccination in chickens. J Vet Med Sci. 2005, 67 (9): 947-949. 10.1292/jvms.67.947.View ArticlePubMedGoogle Scholar
- Li JM, Liu DD, Wang SS, Cao LQ, Tao JP: Isolation and identification of Eimeria mitis, E. necatrix and E. praecox. Proceedings of 11th Conference of Chinese Society of Veterinary Parasitology. 2011, Hubei, Wuhan, 220-http://www.cnki.net/kcms/detail/detail.aspx?dbcode=CPFD&dbName=CPFD2012&FileName=ZGXJ201111001077&v=MjMyODEq02SxuB/Qza6PRWXrCAsTSMwXFJ42CToM5KgbNH6xlSq4n2bibxcp51C%2ByyZeHT8=&uid=WEEvREcwSlJHSldTTGJhYkhncG1XVHdvekRIa0pSbmxiY2R3dDlWMzZFVFFvV0llMFhHTHdVcHpnMnhlZFZsSA,Google Scholar
- Li JM, Liu DD, Wang SS, Cao LQ, Xu JJ, Tao JP: Cloning and sequencing analyze of the internal transcribed spacer of ribosomal DNA for four species of Eimeria and immunological interaction between E. necatrix and E. maxima or E. tenella. Proceedings of 11th Conference of Chinese Society of Veterinary Parasitology. 2011, Hubei, Wuhan, 221-http://www.cnki.net/kcms/detail/detail.aspx?dbcode=CPFD&dbName=CPFD2012&FileName=ZGXJ201111001077&v=MjMyODEq02SxuB/Qza6PRWXrCAsTSMwXFJ42CToM5KgbNH6xlSq4n2bibxcp51C%2ByyZeHT8=&uid=WEEvREcwSlJHSldTTGJhYkhncG1XVHdvekRIa0pSbmxiY2R3dDlWMzZFVFFvV0llMFhHTHdVcHpnMnhlZFZsSA,Google Scholar
- Wagenbach GE, Challey JR, Burns WC: A method for purifying coccidian oocysts employing clorox and sulfuric acid-dichromate solution. J Parasitol. 1966, 52 (6): 1222-10.2307/3276377.View ArticlePubMedGoogle Scholar
- Karim MJ, Basak SC, Trees AJ: Characterization and immunoprotective properties of a monoclonal antibody against the major oocyst wall protein of Eimeria tenella. Infect Immun. 1996, 64 (4): 1227-1232.PubMed CentralPubMedGoogle Scholar
- Belli SI, Wallach MG, Smith NC: Cloning and characterization of the 82 kDa tyrosine-rich sexual stage glycoprotein, GAM82, and its role in oocyst wall formation in the apicomplexan parasite, Eimeria maxima. Gene. 2003, 307: 201-212.View ArticlePubMedGoogle Scholar
- Belli SI, Lee M, Thebo P, Wallach MG, Schwartsburd B, Smith NC: Biochemical characterisation of the 56 and 82 kDa immunodominant gametocyte antigens from Eimeria maxima. Int J Parasitol. 2002, 32 (7): 805-816. 10.1016/S0020-7519(02)00011-5.View ArticlePubMedGoogle Scholar
- Wallach M, Smith NC, Petracca M, Miller CM, Eckert J, Braun R: Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine. 1995, 13 (4): 347-354. 10.1016/0264-410X(95)98255-9.View ArticlePubMedGoogle Scholar
- Stotish RL, Wang CC, Meyenhofer M: Structure and composition of the oocyst wall of Eimeria tenella. J Parasitol. 1978, 64 (6): 1074-1081. 10.2307/3279729.View ArticlePubMedGoogle Scholar
- Mai K, Sharman PA, Walker RA, Katrib M, de Souza D, McConville MJ, Wallach MG, Belli SI, Ferguson DJ, Smith NC: Oocyst wall formation and composition in coccidian parasites. Mem Inst Oswaldo Cruz. 2009, 104 (2): 281-289. 10.1590/S0074-02762009000200022.View ArticlePubMedGoogle Scholar
- Belli SI, Wallach MG, Luxford C, Davies MJ, Smith NC: Roles of tyrosine-rich precursor glycoproteins and dityrosine- and 3,4-dihydroxyphenylalanine-mediated protein cross-linking in development of the oocyst wall in the coccidian parasite Eimeria maxima. Eukaryot Cell. 2003, 2 (3): 456-464. 10.1128/EC.2.3.456-464.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Krucken J, Hosse RJ, Mouafo AN, Entzeroth R, Bierbaum S, Marinovski P, Hain K, Greif G, Wunderlich F: Excystation of Eimeria tenella sporozoites impaired by antibody recognizing gametocyte/oocyst antigens GAM22 and GAM56. Eukaryot Cell. 2008, 7 (2): 202-211. 10.1128/EC.00292-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Morrison DA, Bornstein S, Thebo P, Wernery U, Kinne J, Mattsson JG: The current status of the small subunit rRNA phylogeny of the coccidia (Sporozoa). Int J Parasitol. 2004, 34 (4): 501-514. 10.1016/j.ijpara.2003.11.006.View ArticlePubMedGoogle Scholar
- Meng M, He S, Zhao G, Bai Y, Zhou H, Cong H, Lu G, Zhao Q, Zhu XQ: Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Parasit Vectors. 2012, 5: 273-10.1186/1756-3305-5-273.PubMed CentralView ArticlePubMedGoogle Scholar
- Ferguson DJP, Belli SI, Smith NC, Wallach MG: The development of the macrogamete and oocyst wall in Eimeria maxima: immuno-light and electron microscopy. Int J Parasitol. 2003, 33 (12): 1329-1340. 10.1016/S0020-7519(03)00185-1.View ArticlePubMedGoogle Scholar
- Belli SI, Smith NC, Ferguson DJ: The coccidian oocyst: a tough nut to crack!. Trend Parasitol. 2006, 22 (9): 416-423. 10.1016/j.pt.2006.07.004.View ArticleGoogle Scholar
- Fried M, Mencher D, Sar-Shalom O, Wallach M: Developmental gene expression of a 230-kilodalton macrogamete-specific protein of the avian coccidial parasite, Eimeria maxima. Mol Biochem Parasit. 1992, 51 (2): 251-262. 10.1016/0166-6851(92)90075-U.View ArticleGoogle Scholar
- Belli SI, Ferguson DJ, Katrib M, Slapetova I, Mai K, Slapeta J, Flowers SA, Miska KB, Tomley FM, Shirley MW: Conservation of proteins involved in oocyst wall formation in Eimeria maxima, Eimeria tenella and Eimeria acervulina. Int J Parasitol. 2009, 39 (10): 1063-1070. 10.1016/j.ijpara.2009.05.004.PubMed CentralView ArticlePubMedGoogle Scholar
- Belli SI, Witcombe D, Wallach MG, Smith NC: Functional genomics of gam56: characterisation of the role of a 56 kilodalton sexual stage antigen in oocyst wall formation in Eimeria maxima. Int J Parasitol. 2002, 32 (14): 1727-1737. 10.1016/S0020-7519(02)00212-6.View ArticlePubMedGoogle Scholar
- Pugatsch T, Mencher D, Wallach M: Eimeria maxima: isolation of gametocytes and their immunogenicity in mice, rabbits, and chickens. Exp Parasitol. 1989, 68 (2): 127-134. 10.1016/0014-4894(89)90089-1.View ArticlePubMedGoogle Scholar
- Wallach M, Pillemer G, Yarus S, Halabi A, Pugatsch T, Mencher D: Passive immunization of chickens against Eimeria maxima infection with a monoclonal antibody developed against a gametocyte antigen. Infect Immun. 1990, 58 (2): 557-562.PubMed CentralPubMedGoogle Scholar
- Wallach M, Halabi A, Pillemer G, Sar-Shalom O, Mencher D, Gilad M, Bendheim U, Danforth HD, Augustine PC: Maternal immunization with gametocyte antigens as a means of providing protective immunity against Eimeria maxima in chickens. Infect Immun. 1992, 60 (5): 2036-2039.PubMed CentralPubMedGoogle Scholar
- Hafeez MA, Akhtar M, Javed MT, ul Haq A: Maternal immunization by egg propagated gametocyte vaccine to control Eimeria tenella infections in newly hatched chicks. Parasitol Res. 2007, 100 (5): 1139-1141. 10.1007/s00436-006-0382-x.View ArticlePubMedGoogle Scholar
- Wallach MG: The development of CoxAbic® a novel vaccine against coccidiosis. World Poultry. 2002, 18: 2-4.Google Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.